
Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab
Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS
Biologics Development and Manufacturing Organization CDMO helping to bring life-saving and improving drugs effectively and efficiently to the market.
Biologics Development and Manufacturing Organization CDMO helping to bring life-saving and improving drugs effectively and efficiently to the market.
The Celonic Group is a “Pure Play” Biologics Contract Development Manufacturing Organization (CDMO).
Celonic’s mission is to help its clients, primarily small to large Biotech and Biosimilar Companies, bring life-saving and improving drugs effectively and efficiently to the market.
Celonic is a pioneer in adopting “next generation” bioprocessing technologies such as process intensification and full perfusion lowering the cost of goods per gram to make drugs more accessible to patients.
Celonic offers the expertise like larger CDMO’s with agility and a clear collaboration mindset
Celonic offers end to end drug substance development and manufacturing solutions for monoclonal antibodies, bispecifics and other complex molecules. This ranges from Cell Line Development all the way to Commercial Manufacturing. Fill and Finish is offered via a third party strategic alliance partner.
Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS
The Celonic Group, a “Pure Play” Biologics Contract Development Organization
GS-CHOvolution® is based on Revvity’s CHOSOURCE™ expression platform and TnT